Option Care Health, Inc.(OPCH)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,211 of 2,960 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
OPCH Stock Analysis & AI Quality Score
Data updated 2026-09-12AI stock analysis and institutional research for Option Care Health, Inc. (OPCH), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OPCH at 56.0/100 on a 32-signal composite quality model, placing it at rank #1,211 of 2,960 stocks — the top half of the AI-ranked universe. OPCH scores in the top quartile across revenue scale (79.3). Areas of concern include institutional flow (8.1) and free cash flow (38.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Option Care Health, Inc. reports quarterly revenue of $1.4B, net income of $45.3M, an operating margin of 5.4%. Top institutional holders of OPCH by reported 13-F value include BlackRock, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. OPCH trades on the Nasdaq exchange and files with the SEC under CIK 1014739. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OPCH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Option Care Health, Inc. directly from SEC EDGAR. Option Care Health, Inc.'s 13F Pro composite quality score has ranged between 54 and 69 since 2021, currently 56.0 — a stable long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q1 2026
$1.4B
Net Income
Q1 2026
$45.3M
Free Cash Flow
Q1 2026
$-21.2M
Operating Margin
Q1 2026
5.4%
ROIC
Q1 2026
11.5%
D/E Ratio
Q1 2026
0.86
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+13.0% YoYNet Income
-2.0% YoYOperating Income
+5.0% YoYEPS (Diluted)
+3.3% YoYTotal Assets
+1.0% YoYTotal Debt
+4.5% YoYOp. Cash Flow
-20.1% YoYFree Cash Flow
-24.5% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.65B +13.0% | $5.00B +16.2% | $4.30B +9.1% | $3.94B +14.7% | $3.44B +13.4% | $3.03B |
| Net Income | $207.6M -2.0% | $211.8M -20.7% | $267.1M +77.4% | $150.6M +7.6% | $139.9M +1832.3% | $-8.1M |
| Operating Income | $337.9M +5.0% | $321.8M +2.3% | $314.6M +31.0% | $240.2M +25.9% | $190.8M +72.3% | $110.8M |
| EPS (Diluted) | $1.27 +3.3% | $1.23 -16.9% | $1.48 +78.3% | $0.83 +7.8% | $0.77 +2025.0% | $-0.04 |
| Total Assets | $3.46B +1.0% | $3.42B +6.4% | $3.22B +3.3% | $3.11B +11.5% | $2.79B +5.4% | $2.65B |
| Total Debt | $1.17B +4.5% | $1.12B +4.6% | $1.07B -0.1% | $1.07B -0.2% | $1.07B -5.4% | $1.13B |
| Operating Cash Flow | $258.4M -20.1% | $323.4M -12.9% | $371.3M +38.8% | $267.5M +28.3% | $208.6M +63.7% | $127.4M |
| Free Cash Flow | $217.1M -24.5% | $287.8M -12.6% | $329.4M +41.9% | $232.2M +26.9% | $182.9M +82.0% | $100.5M |
Get alerted when OPCH's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Option Care Health, Inc. including:
Top Institutional Holders of OPCH
BlackRock, Inc.
$463.5M22,104,863 shWELLINGTON MANAGEMENT GROUP LLP
$247.1M11,782,384 shVANGUARD PORTFOLIO MANAGEMENT LLC
$173.5M8,274,458 shFULLER & THALER ASSET MANAGEMENT, INC.
$156.2M7,450,698 shVANGUARD CAPITAL MANAGEMENT LLC
$148.1M7,063,747 shDurable Capital Partners LP
$129.3M6,163,722 shSTATE STREET CORP
$128.8M6,139,898 shARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$125.4M5,980,270 shDIMENSIONAL FUND ADVISORS LP
$114.3M5,449,294 shGEODE CAPITAL MANAGEMENT, LLC
$93.7M4,467,797 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $463.5M | 22,104,863 |
| WELLINGTON MANAGEMENT GROUP LLP | $247.1M | 11,782,384 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $173.5M | 8,274,458 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $156.2M | 7,450,698 |
| VANGUARD CAPITAL MANAGEMENT LLC | $148.1M | 7,063,747 |
| Durable Capital Partners LP | $129.3M | 6,163,722 |
| STATE STREET CORP | $128.8M | 6,139,898 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $125.4M | 5,980,270 |
| DIMENSIONAL FUND ADVISORS LP | $114.3M | 5,449,294 |
| GEODE CAPITAL MANAGEMENT, LLC | $93.7M | 4,467,797 |
Companies Similar to OPCH
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
BrightSpring Health Services, Inc.
Envista Holdings Corp
National Vision Holdings, Inc.
Amneal Pharmaceuticals, Inc.
Alignment Healthcare, Inc.
BRIGHT HORIZONS FAMILY SOLUTIONS INC.
Prestige Consumer Healthcare Inc.
Elanco Animal Health Inc
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put OPCH on your watchlist
Track score changes the day Option Care Health, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is OPCH a good stock to buy?
13F Pro's AI-powered analysis of Option Care Health, Inc. (OPCH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OPCH are available on the OPCH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. OPCH is classified as a mid company.
Which hedge funds own OPCH?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OPCH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Option Care Health, Inc.'s investment landscape.